tiprankstipranks
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market

Chemomab Therapeutics (CMMB) Income Statement

Compare
240 Followers

Chemomab Therapeutics Income Statement

Last quarter (Q2 2024), Chemomab Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Chemomab Therapeutics's net income was $-3.63M. See Chemomab Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -66.83K$ -57.77K$ -34.02K$ -80.00K$ -281.91K
Operating Expenses
$ 25.46M$ 28.53M$ 12.37M$ 5.97M$ 19.33M
Depreciation and Amortization
$ 67.00K$ 57.77K$ 34.02K$ 80.00K$ 281.91K
EBITDA
$ -25.39M$ -28.48M$ -12.33M$ -5.95M$ -26.92M
Operating Income
$ -25.46M$ -28.53M$ -12.40M$ -5.97M$ -19.61M
Other Income/Expenses
$ 1.24M$ 353.00K$ -111.00K$ 21.00K$ -7.60M
Pretax Income
$ -24.22M$ -28.18M$ -12.48M$ -5.95M$ -27.21M
Net Income
$ -24.22M$ -27.65M$ -12.55M$ -5.93M$ -27.21M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.10$ -2.43$ -1.21$ -3.20$ -15.80
Diluted EPS
$ -0.10$ -2.43$ -1.21$ -3.20$ -15.80
Weighted Average Shares Outstanding
234.98M 11.38M 10.37M 1.85M 1.72M
Weighted Average Shares Outstanding (Diluted)
235.00M 11.38M 10.37M 1.85M 1.72M
Currency in USD

Chemomab Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis